The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Transcat Inc's Score
Industry at a Glance
Industry Ranking
21 / 61
Overall Ranking
155 / 4614
Industry
Electronic Equipment & Parts
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
5
analysts
Buy
Current Rating
111.400
Target Price
+101.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Transcat Inc Highlights
StrengthsRisks
Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system (CMMS), and pipette services. It is focused on providing services and products to regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Its segments include Service and Distribution. Its Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. Its Distribution segment sells and rents national and proprietary brand instruments to customers globally. It provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 26 calibration service centers located across the United States, Puerto Rico, Canada, and Ireland.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.75% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 278.42M.
Undervalued
The company’s latest PB is 1.75, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 8.72M shares, decreasing 14.84% quarter-over-quarter.
Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system (CMMS), and pipette services. It is focused on providing services and products to regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Its segments include Service and Distribution. Its Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. Its Distribution segment sells and rents national and proprietary brand instruments to customers globally. It provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 26 calibration service centers located across the United States, Puerto Rico, Canada, and Ireland.